Biopharma Botswana's manufacturing strategy centres on developing tablet and capsule production
capabilities to serve selected essential medicine markets in Botswana and the wider region.
Our approach is intended to balance local manufacturing opportunities with international technical expertise,
reliable raw material sourcing and the quality standards required for pharmaceutical production.
Our initial manufacturing focus is on solid oral dosage forms, including tablets and capsules. These formulations are
widely used across healthcare settings and offer a potential foundation for developing a scalable pharmaceutical manufacturing operation.
Product selection will be guided by market demand, technical feasibility, regulatory requirements and commercial viability.
Our approach is intended to balance local manufacturing opportunities with international technical expertise,
reliable raw material sourcing and the quality standards required for pharmaceutical production.
Accurate medical tests providing clear insights for timely and effective treatment decisions.
Read MoreAccurate medical tests providing clear insights for timely and effective treatment decisions.
Read MoreAccurate medical tests providing clear insights for timely and effective treatment decisions.
Read MoreWe aim to establish manufacturing capabilities through a structured approach that may include:
Pharmaceutical technology transfer and technical collaboration.
Partnerships with established pharmaceutical manufacturers.
Reliable sourcing of active pharmaceutical ingredients (APIs) and other production inputs.
Development of appropriate manufacturing facilities, equipment and processes.
Recruitment and development of skilled local personnel.
Implementation of pharmaceutical quality management and regulatory systems.
Quality must be fundamental to every stage of pharmaceutical manufacturing, from sourcing raw materials to producing, testing, storing and distributing finished medicines.
Biopharma Botswana's manufacturing development will need to align with applicable Botswana regulatory
requirements and relevant international good manufacturing practice (GMP) standards.
The objective is to establish processes that support product quality, patient safety, traceability and consistent production.
While the initial focus is on tablets and capsules, the broader platform is intended to allow for future product
expansion as demand, technical capabilities, regulatory approvals and investment permit.
Biopharma Botswana's manufacturing strategy centres on developing tablet and capsule production capabilities to serve selected essential medicine markets in Botswana and the wider region.
Our initial manufacturing focus is on solid oral dosage forms, including tablets and capsules. These formulations are
widely used across healthcare settings and offer a potential foundation for developing a scalable pharmaceutical manufacturing operation.
Product selection will be guided by market demand, technical feasibility, regulatory requirements and commercial viability.
Our approach is intended to balance local manufacturing opportunities with international technical expertise, reliable raw material sourcing and the quality standards required for pharmaceutical production.
No posts found.
Copyright @ 2026 Biopharma Botswana
Designed By Zuri Media